Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Cash back taxes can be confusing. This guide provides essential insights to help you navigate your tax responsibilities.
22,227 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A lithium-tech startup has joined the unicorn ranks after securing major funding and a government loan, underscoring ...
A quiet, data-driven move by Endeavour Capital Advisors boosted its stake in QCR Holdings in Q1 2026. Learn what this...
In May 2026, additive manufacturing stocks are catching fresh interest as manufacturers push for faster production cy...
AST SpaceMobile posted a Q1 2026 revenue miss but reaffirmed full-year guidance and outlined a rapid satellite deploy...
AI disruption is reshaping entry-level jobs, pushing the next generation to consider space-based careers. This report...
Goldman Sachs raises Enphase Energy's price target to 57 and maintains a Buy rating, highlighting a nascent rebound i...
Tesla’s stock price problem remains in focus as shares hover in a tight range amid mixed demand data and bets on AI v...
A disciplined, calendar-driven approach to investing is gaining ground as markets swing on tariff news and rate moves...
A profile of the country’s only full-time spelling bee coach, whose high hourly rate and prize-based bonuses are resh...
Regulated XRP ETFs have opened a convenient on-ramp to Ripple exposure. This story breaks down how (ripple) beginners...
Solana’s network momentum is rising in early 2026, yet a persistent FTX estate overhang and waning ETF inflows keep t...